Cheryl Jacobs Smith
About Cheryl Jacobs Smith
Cheryl Jacobs Smith is a Health Science Policy Analyst at the National Institutes of Health, where she has worked since 2016. She focuses on managing sensitive genomic data and promoting health equity through policy initiatives.
Work at National Institutes of Health
Cheryl Jacobs Smith has been employed at the National Institutes of Health (NIH) as a Health Science Policy Analyst since 2016. In this role, she supports the NIH HeLa Data Submission and Access Policy, which involves managing sensitive genomic data. Her work includes overseeing initiatives that focus on the ethical and responsible sharing of genomic information in healthcare. Additionally, she promotes health equity through various policy initiatives at the NIH.
Previous Experience at National Cancer Institute
Before her current position at NIH, Cheryl Jacobs Smith worked as a Postdoctoral Fellow at the National Cancer Institute (NCI) from 2014 to 2016. During her two years at NCI, she contributed to research and policy development in the field of cancer genomics, further enhancing her expertise in health science policy.
Educational Background in Human Genetics
Cheryl Jacobs Smith pursued her education at the University of Michigan, where she completed her PhD in Human Genetics from 2007 to 2014. She also earned a Master of Science (MS) in Human Genetics from the same institution between 2007 and 2009. Her academic journey began at Hope College, where she obtained a Bachelor of Science (BS) in Biology from 2003 to 2007.
Focus on Ethical Sharing of Genomic Information
In her role at the NIH, Cheryl Jacobs Smith oversees initiatives that emphasize the ethical and responsible sharing of genomic information within healthcare. This focus is crucial in ensuring that genomic data is utilized effectively while maintaining privacy and ethical standards.
Promotion of Health Equity Initiatives
Cheryl Jacobs Smith is actively involved in promoting health equity through various policy initiatives at the NIH. Her work aims to address disparities in healthcare access and outcomes, ensuring that genomic advancements benefit diverse populations.